Document Detail

Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis.
Jump to Full Text
MedLine Citation:
PMID:  23722974     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective:Earlier diagnosis and treatment of necrotizing enterocolitis (NEC) in preterm infants, before clinical deterioration, might improve outcomes. A monitor that measures abnormal heart rate characteristics (HRC) of decreased variability and transient decelerations was developed as an early warning system for sepsis. As NEC shares pathophysiologic features with sepsis, we tested the hypothesis that abnormal HRC occur before clinical diagnosis of NEC.Study Design:Retrospective review of Bells stage II to III NEC cases among infants <34 weeks gestation enrolled in a prospective randomized clinical trial of HRC monitoring at three neonatal intensive care units.Result:Of 97 infants with NEC and HRC data, 33 underwent surgical intervention within 1 week of diagnosis. The baseline HRC index from 1 to 3 days before diagnosis was higher in patients who developed surgical vs medical NEC (2.06±1.98 vs 1.22±1.10, P=0.009). The HRC index increased significantly 16 h before the clinical diagnosis of surgical NEC and 6 h before medical NEC. At the time of clinical diagnosis, the HRC index was higher in patients with surgical vs medical NEC (3.3±2.2 vs 1.9±1.7, P<0.001).Conclusion:Abnormal HRC occur before clinical diagnosis of NEC, suggesting that continuous HRC monitoring may facilitate earlier detection and treatment.Journal of Perinatology advance online publication, 30 May 2013; doi:10.1038/jp.2013.63.
Authors:
M L Stone; P M Tatum; J-H Weitkamp; A B Mukherjee; J Attridge; E D McGahren; B M Rodgers; D E Lake; J R Moorman; K D Fairchild
Related Documents :
21389794 - The preventcd study design: towards new strategies for the prevention of coeliac disease.
25419594 - Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile ac...
4040604 - Ethanol-induced late fetal death in mice exposed around the time of fertilization.
25315494 - Characterization of the vitamin a transport in preterm infants after repeated high-dose...
11159154 - Implausible birth weight for gestational age.
19185924 - Newborn hearing screening and strategy for early detection of hearing loss in infants.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-5-30
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  -     ISSN:  1476-5543     ISO Abbreviation:  J Perinatol     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-5-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Surgery, University of Virginia, Charlottesville, VA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-journal-id): 8501884
Journal ID (pubmed-jr-id): 5061
Journal ID (nlm-ta): J Perinatol
Journal ID (iso-abbrev): J Perinatol
ISSN: 0743-8346
ISSN: 1476-5543
Article Information
Download PDF

License:
nihms-submitted publication date: Day: 28 Month: 3 Year: 2014
Electronic publication date: Day: 30 Month: 5 Year: 2013
Print publication date: Month: 11 Year: 2013
pmc-release publication date: Day: 19 Month: 5 Year: 2014
Volume: 33 Issue: 11
First Page: 847 Last Page: 850
PubMed Id: 23722974
ID: 4026091
DOI: 10.1038/jp.2013.63
ID: NIHMS471467

Abnormal Heart Rate Characteristics Prior to Clinical Diagnosis of Necrotizing Enterocolitis
Matthew L. Stone, MD1
Philip M. Tatum, MD4
Jörn-Hendrik Weitkamp, MD5
Anamika B. Mukherjee, MD5
Joshua Attridge, MD6
Eugene D. McGahren, MD12
Bradley M. Rodgers, MD12
Douglas E. Lake, PhD3
J. Randall Moorman, MD3
Karen D. Fairchild, MD2
1Department of Surgery, The University of Virginia, Charlottesville, Virginia
2Department of Pediatrics, The University of Virginia, Charlottesville, Virginia
3Department of Internal Medicine, The University of Virginia, Charlottesville, Virginia
4Department of Pediatrics, Wake Forest University, Winston-Salem, North Carolina
5Department of Pediatrics, Vanderbilt University, Nashville, Tennessee
6Department of Pediatrics, Children's National Medical Center, Washington, DC
Correspondence: Corresponding author: Karen D. Fairchild, MD Department of Pediatrics University of Virginia Health System P.O. Box 800386 Charlottesville, Virginia 22908 kdf2n@virginia.edu Phone: (434) 924-5428 Fax: (434) 982-4387

Introduction

Necrotizing enterocolitis (NEC) is the most common acquired intestinal disease of preterm infants, and despite advances in neonatal intensive care unit (NICU) care, mortality may be as high as 30%. 1, 2, 3 Survivors of NEC have longer hospital stay and are at risk for long-term nutritional and neurologic problems. 4, 5, 6 A major challenge toward improving outcomes is identifying and treating infants in the early stages of NEC, when clinical signs may be subtle and nonspecific. Once more definitive signs appear, adverse outcomes such as extensive bowel necrosis leading to death or short bowel syndrome are more likely.7 Discovering markers of NEC that appear prior to overt clinical signs would facilitate earlier goal-directed therapies which could improve outcomes.

Abnormal heart rate characteristics (HRC) have been established as a biomarker for late-onset neonatal sepsis and mortality in NICU patients.8 Our group has shown that reduced heart rate variability and repetitive transient decelerations often occur in the preclinical phase of sepsis.9 This finding inspired the development of a monitor that calculates an HRC index, a mathematical representation of decreased beat-to-beat variability and decelerations which is the fold-increase in probability of sepsis being diagnosed in the next 24 hours. 10, 11 In a recent randomized clinical trial of 3003 infants, HRC monitoring reduced mortality in VLBW infants from 10.2% to 8.1%, a statistically significant and clinically meaningful result. 12

Necrotizing enterocolitis and sepsis share pathophysiologic features, including a systemic inflammatory response,13 hemodynamic compromise, and organ hypoperfusion.14 We and others have shown that elevated circulating levels of proinflammatory cytokines contribute to decreased heart rate variability 15, 16, 17, 18 In NEC, serum cytokines are elevated, particularly when there is significant intestinal necrosis or associated bacteremia.19 Intestinal hypomotility, ileus, and bowel distension have also been associated with increased vagal tone and altered heart rate characteristics in adults.20, 21 Our studies in preclinical models indicate that peritoneal administration of bacteria or fungi activates vagus nerve pathways leading to transient heart rate decelerations similar to those seen in neonates with sepsis.22 Heart rate characteristics changes may thus reflect activation of the cholinergic anti-inflammatory pathway which plays a critical role in host defense.23

Abnormal heart rate characteristics have not previously been studied in infants with NEC, and we therefore undertook a retrospective review of cases of NEC in VLBW infants during a prospective randomized clinical trial of HRC monitoring. Our goal was to determine whether the HRC index could identify patients in the early, preclinical phase of disease when aggressive treatment may improve outcomes.


Methods
Study population

We retrospectively identified all cases of NEC Bell's stage II to III24 in very low birth weight (VLBW <1500 grams) infants admitted from January 2005 to April 2010 to 3 centers participating in a prospective randomized clinical trial (RCT) of HRC monitoring. In the HRC (HeRO) RCT, 3003 VLBW infants in 9 NICUs had HRC continuously monitored and were randomized to having their HRC index displayed to clinicians, or not displayed, then followed for 120 days or until death or NICU discharge. Results of this study were published in 2011.12 Institutional Review Boards of each institution approved the RCT, which required parental consent, and approved retrospective review of deidentified patient data for the current analysis. The three centers participating in the current analysis were the University of Virginia, Wake Forest University (Brenner Children's Hospital and Forsyth Medical Center), and Vanderbilt University. At the University of Virginia, the principle site for the RCT, VLBW infants not enrolled in the HRC trial had HRC monitored but not displayed to clinicians. At the other units, infants not enrolled in the RCT did not have HRC monitored.

NEC diagnosis and clinical features

Through database review, we identified all cases of NEC in the three centers in the date range indicated above, and then identified cases meeting the following criteria: less than 34 weeks gestational age, clinical and radiographic evidence of Bell's stage II to III NEC, at least 7 days of age at diagnosis, and at least 7 days of treatment with bowel rest and antibiotics. Clinical signs included abdominal distention, ileus, and hematochezia. Radiographic signs included fixed dilated loops, pneumatosis intestinalis, portal venous gas, and pneumoperitoneum. We excluded patients in whom a diagnosis of spontaneous intestinal perforation was made at the time of laparotomy, as well as repeat episodes of NEC in the same patient.

Medical records were reviewed for demographic and clinical variables. The time of NEC diagnosis was defined as the time of the initial abdominal radiograph that led to the diagnosis of NEC. Cases were classified as medical or surgical, the latter defined as peritoneal drain placement or laparotomy within 7 days of NEC diagnosis. Mortality was considered within 14 days of NEC diagnosis.

Heart rate characteristics index monitoring

The heart rate characteristics (HeRO) monitor (Medical Predictive Science Corporation, Charlottesville, VA) uses the electrocardiogram from standard NICU bedside monitors to continuously calculate an HRC index. The mathematical algorithm from which the HRC index is derived incorporates decreased variability and transient decelerations and, using logistic regression, is the fold increase in probability of sepsis being diagnosed in the next 24 hours. The monitor continuously displays the HRC index which is updated hourly and represents HRC over the previous 12 hours. In the randomized trial, clinicians were educated about the HRC index but no course of action was mandated for patients with a rising score.

Statistical analysis

Comparisons of hourly HRC index between the two groups (medical and surgical NEC) were made by t-test for continuous variables and Fisher's exact test for categorical variables. Paired signed rank test was used to analyze the rise in the HRC index before NEC diagnosis. Average HRC index ± standard deviation is given, unless otherwise noted. Statistical analyses were performed in MatLab (MathWorks, Natick, MA) with a two-tailed level of significance of 0.05.


Results
Patient demographics and clinical course

We identified 97 episodes of NEC Bell's stage II to III in VLBW infants <34 weeks gestation with heart rate characteristics data available at the time of diagnosis. 33 of these patients underwent either laparotomy or peritoneal drain placement within 7 days of diagnosis and were classified as surgical NEC for this analysis. Clinical characteristics and outcomes are shown in Table 1. Patients that had surgical intervention (laparotomy or peritoneal drain placement) within one week of NEC diagnosis were of lower gestational age, were more likely to have a positive blood culture, and were more likely to die within 14 days of NEC diagnosis.

Figure 1 shows screen shots from the HRC monitor, with representative examples of normal HRC and abnormal HRC occurring prior to clinical presentation of NEC.

HRC index in infants with medical and surgical NEC

The baseline HRC index from 1 to 3 days before NEC diagnosis was higher in patients who developed surgical versus medical NEC (2.06 ± 1.98 vs. 1.22 ± 1.10, p=0.009), and this difference persisted after adjustment for gestational age and birth weight. In the hours leading up to the clinical diagnosis of NEC, there was a significant rise in the HRC index over patients’ prior 24 hour baseline (Figure 2). This occurred 16 hours before clinical diagnosis of surgical NEC and 6 hours prior to diagnosis of medical NEC.

At the time of diagnosis, patients with surgical NEC had a higher average HRC index compared to those with medical NEC (3.3 ± 2.2 vs 1.9 ± 1.7, p<0.001), and patients who died had a higher HRC index compared with survivors (4.0 ± 1.9 vs. 2.5 ± 1.7, p=0.004) (Table 1). Blood culture within 24 hours of NEC diagnosis was positive in 22 cases, negative in 74, and not obtained in 1. The HRC index in patients with a positive blood culture was 3.0 ± 1.5 and in those with a negative blood culture was 2.6 ± 1.9, (p=0.44). Considering only patients with a negative blood culture at the time of NEC diagnosis, there was a significantly higher HRC index in those with surgical compared to those with medical NEC (3.8 ± 2.0 vs. 2.2 ± 1.7, p=0.007).

After NEC diagnosis, the HRC index increased in both groups, peaking 15 hours after clinical diagnosis (Figure 2). Of note, general anesthesia and surgery lead to abnormal heart rate characteristics, and the figure therefore displays the HRC index only prior to surgical intervention.

HRC index display versus non-display

Of the 97 patients with NEC, 88 had been enrolled, with parental consent, in a randomized clinical trial in which the HRC index was either displayed to clinicians or not displayed (47 randomized to HRC display and 41 to non-display). The remaining 9 patients were at the University of Virginia and were not enrolled in the RCT but had HRC monitored and not displayed to clinicians, per unit protocol. Thus, there were 47 patients with HRC displayed and 50 non-displayed. Figure 3 shows the HRC index around the time of NEC diagnosis in patients in the non-display group compared to the HRC display group..


Discussion

Identification of biomarkers for prediction or early detection of NEC has been the subject of intense investigation, which is appropriate given the high incidence and potentially devastating consequences of the disease. In the current analysis of VLBW infants admitted to 3 centers during a randomized clinical trial of heart rate characteristics monitoring, we found that abnormal HRC similar to those seen in sepsis also occur in preterm infants prior to clinical presentation of NEC. If clinicians are alerted to this physiologic change they may be prompted to closely evaluate the patient and consider further testing and treatment, potentially leading to improved outcomes through early intervention.

Prior studies of NEC biomarkers have not yet yielded clinically useful tests. Daily calculation of the Score for Neonatal Acute Physiology-II (SNAP-II), which includes measures of hypotension, hypothermia, acidosis, and oxygenation, was shown not to predict or detect NEC. 25 Genetic susceptibility testing, breath hydrogen sampling, and testing for inflammatory markers in blood or stool have all been shown to have limited diagnostic value.26 Measurements of altered mesenteric blood flow27, 28 and changes in intestinal microbiota 29 show promise for predicting or detecting NEC but are in early stages of investigation. Our study indicates that a commercially available monitor that is FDA-cleared for reporting on abnormal heart rate characteristics in neonates can detect biological changes associated with NEC up to a day before clinicians recognize that a patient is ill.

Abnormal heart rate characteristics of decreased variability and decelerations were discovered by our group to be strongly associated with late-onset sepsis in preterm infants.9, 30, 31, 32 Since NEC shares pathophysiologic features with sepsis it is not surprising that HRC are abnormal in infants at the time of diagnosis of NEC. The systemic inflammatory response, intestinal distension, and tissue necrosis may all contribute indirectly (via autonomic nervous system activation and dysfunction) or directly (via effects on sinoatrial node pacemaker cells) to abnormal heart rate characteristics. In the current analysis we found that the HRC index continued to rise after diagnosis and the start of treatment of NEC, in contrast to sepsis where we previously have shown that peak HRC occurs near the time of diagnosis and declines after antibiotics and other therapies are started. The continued worsening of HRC in patients with NEC parallels the clinical course in these infants in whom a dramatic systemic inflammatory response and, in some cases, significant bowel necrosis, often lead to progressive clinical deterioration even after initiation of therapy. The clinical relevance of this finding is that, in NICU patients started on antibiotics for suspected infection, a continued rise in the HRC index could be a sign of an ongoing inflammatory process and should lead to careful clinical assessment and consideration of additional studies or therapies.

Most patients in the current analysis were participating in a randomized clinical trial of 3003 VLBW infants in which the HRC index was monitored in all infants but displayed to clinicians in only half. In this large clinical trial, mortality was significantly reduced in patients who had their HRC index continuously displayed. In the current analysis, we did not find a statistically significant difference in the average HRC index prior to NEC diagnosis in infants in the HRC display and non-display groups. A limitation of the current analysis is that the number of infants was small, and in the randomized clinical trial there was no mandated intervention for infants with an acute rise in their HRC index. A larger number of infants with NEC would be required to determine whether display of the HRC index leads to earlier treatment or improved outcomes

Conclusion

Earlier diagnosis of NEC and institution of therapies to decrease the metabolic demand (bowel rest), reduce intestinal distension (gastric decompression), treat infection (broad-spectrum antibiotics), and optimize tissue oxygen delivery (fluid resuscitation and blood pressure support) may improve outcomes. Newer therapies for NEC such as anti-inflammatory agents 33 may also be more effective if patients can be identified in the early phases of illness. Continuous monitoring of heart rate characteristics provides clinicians with information about subtle physiologic changes associated with the systemic inflammatory response that proceed clinical deterioration associated with NEC, raising the possibility of improving patient outcomes through earlier intervention.


Funding: National Institutes of Health (grant R01-HD48562 to J.R.M.)


References
1. Guthrie SO,Gordon PV,Thomas V,Thorp JA,Peabody J,Clark RH. Necrotizing enterocolitis among neonates in the United States.Journal of perinatology: official journal of the California Perinatal AssociationYear: 200323427828512774133
2. Thyoka M,de Coppi P,Eaton S,Khoo K,Hall NJ,Curry J,et al. Advanced necrotizing enterocolitis part 1: mortality.European journal of pediatric surgery: official journal of Austrian Association of Pediatric Surgery [et al] = Zeitschriftfur KinderchirurgieYear: 2012221812
3. Clark RH,Gordon P,Walker WM,Laughon M,Smith PB,Spitzer AR. Characteristics of patients who die of necrotizing enterocolitis.J PerinatolYear: 201232319920421593813
4. Martin CR,Dammann O,Allred EN,Patel S,O'Shea TM,Kuban KC,et al. Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia.The Journal of pediatricsYear: 20101575751756e75120598317
5. Catlin A. Extremely long hospitalizations of newborns in the United States: data, descriptions, dilemmas.Journal of perinatology : official journal of the California Perinatal AssociationYear: 2006261274274817080096
6. Roze E,Ta BD,MH VDR,Tanis JC,VANB KN,Hulscher JB,et al. Functional impairments at school age of children with necrotizing enterocolitis or spontaneous intestinal perforation.Pediatr ResYear: 201170661962521857378
7. Abdullah F,Zhang Y,Camp M,Mukherjee D,Gabre-Kidan A,Colombani PM,et al. Necrotizing enterocolitis in 20,822 infants: analysis of medical and surgical treatments.Clin Pediatr (Phila)Year: 201049216617120080523
8. Griffin MP,Lake DE,Bissonette EA,Harrell FE Jr.,O'Shea TM,Moorman JR. Heart rate characteristics: novel physiomarkers to predict neonatal infection and death.PediatricsYear: 200511651070107416263991
9. Griffin MP,Moorman JR. Toward the early diagnosis of neonatal sepsis and sepsis-like illness using novel heart rate analysis.PediatricsYear: 200110719710411134441
10. Kovatchev BP,Farhy LS,Cao H,Griffin MP,Lake DE,Moorman JR. Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome.Pediatric researchYear: 200354689289812930915
11. Moorman JR,Delos JB,Flower AA,Cao H,Kovatchev BP,Richman JS,et al. Cardiovascular oscillations at the bedside: early diagnosis of neonatal sepsis using heart rate characteristics monitoring.Physiological measurementYear: 2011Year: 1821-18323211
12. Moorman JR,Carlo WA,Kattwinkel J,Schelonka RL,Porcelli PJ,Navarrete CT,et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial.The Journal of pediatricsYear: 20111596900906e90121864846
13. Nanthakumar N,Meng D,Goldstein AM,Zhu W,Lu L,Uauy R,et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response.PLoS OneYear: 201163e1777621445298
14. Caplan MS,Jilling T. New concepts in necrotizing enterocolitis.Curr Opin PediatrYear: 200113211111511317050
15. Aronson D,Mittleman MA,Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure.J Cardiovasc ElectrophysiolYear: 200112329430011291801
16. Fairchild KD,Saucerman JJ,Raynor LL,Sivak JA,Xiao Y,Lake DE,et al. Endotoxin depresses heart rate variability in mice: cytokine and steroid effects.Am J Physiol Regul Integr Comp PhysiolYear: 20092974R1019102719657103
17. Jan BU,Coyle SM,Macor MA,Reddell M,Calvano SE,Lowry SF. Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure.ShockYear: 201033436336820407404
18. Raynor LL,Saucerman JJ,Akinola MO,Lake DE,Moorman JR,Fairchild KD. Cytokine screening identifies NICU patients with Gram-negative bacteremia.Pediatr ResYear: 201271326126622278182
19. Chan KY,Leung FW,Lam HS,Tam YH,To KF,Cheung HM,et al. Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants.PloS oneYear: 201275e3697722606320
20. Pancoto JA,Correa PB,Oliveira-Pelegrin GR,Rocha MJ. Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture.Autonomic neuroscience: basic & clinicalYear: 20081381-2576318060845
21. Budzynski J,Klopocka M,Bujak R,Swiatkowski M,Pulkowski G,Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability.European journal of gastroenterology & hepatologyYear: 200416545145715097036
22. Fairchild KD,Srinivasan V,Moorman JR,Gaykema RP,Goehler LE. Pathogen-induced heart rate changes associated with cholinergic nervous system activation.Am J Physiol Regul Integr Comp PhysiolYear: 20113002R33033921068197
23. Huston JM,Tracey KJ. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy.J Intern MedYear: 20112691455321158977
24. Bell MJ,Ternberg JL,Feigin RD,Keating JP,Marshall R,Barton L,et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.Ann SurgYear: 1978187117413500
25. Lim L,Rozycki HJ. Postnatal SNAP-II scores in neonatal intensive care unit patients: relationship to sepsis, necrotizing enterocolitis, and death.J Matern Fetal Neonatal MedYear: 200821641541918570120
26. Young C,Sharma R,Handfield M,Mai V,Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?Pediatric researchYear: 2009655 Pt 291R97R
27. Cortez J,Gupta M,Amaram A,Pizzino J,Sawhney M,Sood BG. Noninvasive evaluation of splanchnic tissue oxygenation using near-infrared spectroscopy in preterm neonates.The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal ObstetYear: 2011244574582
28. Oh S,Young C,Gravenstein N,Islam S,Neu J. Monitoring technologies in the neonatal intensive care unit: implications for the detection of necrotizing enterocolitis.JPerinatolYear: 2010301170170820336080
29. Mai V,Young CM,Ukhanova M,Wang X,Sun Y,Casella G,et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis.PloS oneYear: 201166e2064721674011
30. Griffin MP,Lake DE,O'Shea TM,Moorman JR. Heart rate characteristics and clinical signs in neonatal sepsis.Pediatr ResYear: 200761222222717237726
31. Griffin MP,Lake DE,Moorman JR. Heart rate characteristics and laboratory tests in neonatal sepsis.PediatricsYear: 2005115493794115805367
32. Griffin MP,O'Shea TM,Bissonette EA,Harrell FE Jr.,Lake DE,Moorman JR. Abnormal heart rate characteristics preceding neonatal sepsis and sepsislike illness.Pediatr ResYear: 200353692092612646726
33. Grave GD,Nelson SA,Walker WA,Moss RL,Dvorak B,Hamilton FA,et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop.Pediatr ResYear: 200762451051417667844

Article Categories:
  • Article

Keywords: neonatal intensive care unit, preterm infant, heart rate variability, predictive monitoring.

Previous Document:  Biomedical applications of sodium MRI in vivo.
Next Document:  Double disclosure bind: complexities of communicating an HIV diagnosis in the context of unintended ...